A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19578766

Download in:

View as

General Info

PMID
19578766